Cholesterol content in brains of suicide completers

International Journal of Neuropsychopharmacology

Volumn 10, Issue 2, 2007, Pages 159-166

  Lalovic, Aleksandra ^a   Levy, Emile ^b   Luheshi, Giamal ^a   Canetti, Lilian ^a   Grenier, Emilie ^b   Sequeira, Adolfo ^a   Turecki, Gustavo ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Frontal cortex; Lipid metabolism; Post mortem; Suicidality; Violence

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; AUTOPSY; BRAIN TISSUE; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; GRAY MATTER; HUMAN; HUMAN TISSUE; LIPID METABOLISM; MAJOR DEPRESSION; MALE; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; VIOLENCE;

ADULT; AUTOPSY; BRAIN; BRAIN CHEMISTRY; CHOLESTEROL; FEMALE; HUMANS; LIPID METABOLISM; MALE; NERVE TISSUE PROTEINS; SUICIDE; VIOLENCE;

EID: 33847076859     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706006663     Document Type: Article

References (51)

1. Alvarez JC, Cremniter D, Gluck N, Quintin P, Leboyer M, Berlin I, Therond P, Spreux-Varoquaux O (2000). Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Research 95, 103-108.
2. Alvarez JC, Cremniter D, Lesieur P, Gregoire A, Gilton A, Macquin-Mavier I, Jarreau C, Spreux-Varoquaux O (1999). Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biological Psychiatry 45, 1066-1069.
3. Arango V, Underwood MD, Gubbi AV, Mann JJ (1995). Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Research 688, 121-133.
4. Arango V, Underwood MD, Mann JJ (1997). Postmortem findings in suicide victims. Implications for in vivo imaging studies. Annals of the New York Academy of Sciences 836, 269-287.
5. Asberg M, Traskman L, Thoren P (1976). 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Archives of General Psychiatry 33, 1193-1197.
6. Bechara A, Damasio H, Tranel D, Damasio AR (1997). Deciding advantageously before knowing the advantageous strategy. Science 275, 1293-1295.
7. Bjorkhem I, Meaney S (2004). Brain cholesterol: long secret life behind a barrier. Arteriosclerosis, Thrombosis, and Vascular Biology 24, 806-815.
8. Dietschy JM, Turley SD (2001). Cholesterol metabolism in the brain. Current Opinion in Lipidology 12, 105-112.
9. Dietschy JM, Turley SD (2004). Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. Journal of Lipid Research 45, 1375-1397.
10. Dumais A, Lesage AD, Lalovic A, Seguin M, Tousignant M, Chawky N, Turecki G (2005). Is violent method of suicide a behavioral marker of lifetime aggression? American Journal of Psychiatry 162, 1375-1378.
11. Elias ER, Irons MB, Hurley AD, Tint GS, Salen G (1997). Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). American Journal of Medical Genetics 68, 305-310.
12. Ellison LF, Morrison HI (2001). Low serum cholesterol concentration and risk of suicide. Epidemiology 12, 168-172.
13. Engelberg H (1992). Low serum cholesterol and suicide. Lancet 339, 727-729.
14. Folch J, Lees M, Sloane Stanley GH (1957). A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry 226, 497-509.
15. Gimpl G, Burger K, Fahrenholz F (1997). Cholesterol as modulator of receptor function. Biochemistry 36, 10959-10974.
16. Golomb BA (1998). Cholesterol and violence: is there a connection? Annals of Internal Medicine 128, 478-487.
17. Horn NR, Dolan M, Elliott R, Deakin JF, Woodruff PW (2003). Response inhibition and impulsivity: an fMRI study. Neuropsychologia 41, 1959-1966.
18. Jollant F, Bellivier F, Leboyer M, Astruc B, Torres S, Verdier R, Castelnau D, Malafosse A, Courtet P (2005). Impaired decision making in suicide attempters. American Journal of Psychiatry 162, 304-310.
19. Kaplan JR, Manuck SB, Shively C (1991). The effects of fat and cholesterol on social behavior in monkeys. Psychosomatic Medicine 53, 634-642.
20. Kaplan JR, Shively CA, Fontenot MB, Morgan TM, Howell SM, Manuck SB, Muldoon MF, Mann JJ (1994). Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys. Psychosomatic Medicine 56, 479-484.
21. Kim C, Lesage A, Seguin M, Chawky N, Vanier C, Lipp O, Turecki G (2003). Patterns of co-morbidity in male suicide completers. Psychological Medicine 33, 1299-1309.
22. Koudinov AR, Koudinova NV (2001). Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB Journal 15, 1858-1860.
23. Koudinov AR, Koudinova NV (2003). Cholesterol, synaptic function and Alzheimers disease. Pharmacopsychiatry 36 (Suppl. 2), S107-S112.
24. Kunugi H, Takei N, Aoki H, Nanko S (1997). Low serum cholesterol in suicide attempters. Biological Psychiatry 41, 196-200.
25. Lalovic A, Merkens L, Russell L, Arsenault-Lapierre G, Nowaczyk MJ, Porter FD, Steiner RD, Turecki G (2004). Cholesterol metabolism and suicidality in Smith-Lemli-Opitz syndrome carriers. American Journal of Psychiatry 161, 2123-2126.
26. Lesage AD, Boyer R, Grunberg F, Vanier C, Morissette R, Menard-Buteau C, Loyer M (1994). Suicide and mental disorders: a case-control study of young men. American Journal of Psychiatry 151, 1063-1068.
27. Levy E, Garofalo C, Rouleau T, Gavino V, Bendayan M (1996). Impact of essential fatty acid deficiency on hepatic sterol metabolism in rats. Hepatology 23, 848-857.
28. Levy E, Thibault L, Menard D (1992). Intestinal lipids and lipoproteins in the human fetus: modulation by epidermal growth factor. Journal of Lipid Research 33, 1607-1617.
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265-275.
30. Mann JJ (1998). The neurobiology of suicide. Nature Medicine 4, 25-30.
31. Mann JJ (2003). Neurobiology of suicidal behaviour. Nature Reviews Neuroscience 4, 819-828.
32. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW (2001). CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357.
33. Mavaddat N, Kirkpatrick PJ, Rogers RD, Sahakian BJ (2000). Deficits in decision-making in patients with aneurysms of the anterior communicating artery. Brain 123, 2109-2117.
34. Modai I, Valevski A, Dror S, Weizman A (1994). Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. Journal of Clinical Psychiatry 55, 252-254.
35. Pfrieger FW (2003a). Cholesterol homeostasis and function in neurons of the central nervous system. Cellular and Molecular Life Sciences 60, 1158-1171.
36. Pfrieger FW (2003b). Role of cholesterol in synapse formation and function. Biochimica et Biophysica Acta 1610, 271-280.
37. Porter JA, Young KE, Beachy PA (1996). Cholesterol modification of hedgehog signaling proteins in animal development. Science 274, 255-259.
38. Pucadyil TJ, Chattopadhyay A (2004). Cholesterol modulates ligand binding and G-protein coupling to serotonin(1A) receptors from bovine hippocampus. Biochimica et Biophysica Acta 1663, 188-200.
39. Rogers RD, Owen AM, Middleton HC, Williams EJ, Pickard JD, Sahakian BJ, Robbins TW (1999). Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. Journal of Neuroscience 19, 9029-9038.
40. Scanlon SM, Williams DC, Schloss P (2001). Membrane cholesterol modulates serotonin transporter activity. Biochemistry 40, 10507-10513.
41. Sequeira A, Gwadry FG, ffrench-Mullen JMH, Canetti L, Gingras Y, Casero Jr. RA, Rouleau G, Benkelfat C, Turecki G (2006). Implication of SSAT by gene expression and genetic variation in suicide and major depression. Archives of General Psychiatry 63, 35-48.
42. Shallice T, Burgess P (1996). The domain of supervisory processes and temporal organization of behaviour. Philosophical Transactions of the Royal Society of London, B: Biological Sciences 351, 1405-1411.
43. Turecki G (2005). Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. Journal of Psychiatry and Neuroscience 30, 398-408.
44. Turecki G, Briere R, Dewar K, Antonetti T, Lesage AD, Seguin M, Chawky N, Vanier C, Alda M, Joober R, Benkelfat C, Rouleau GA (1999). Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. American Journal of Psychiatry 156, 1456-1458.
45. Turecki G, Lalovic A (2005). The biology and genetics of suicidality. In: Licinio J, Wong M-L (Eds.), Biology of Depression: From Novel Insights to Therapeutic Strategies (pp. 287-316). Weinheim: Wiley-VCH.
46. Vevera J, Fisar Z, Kvasnicka T, Zdenek H, Starkova L, Ceska R, Papezova H (2005). Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Research 133, 197-203.
47. Vevera J, Zukov I, Morcinek T, Papezova H (2003). Cholesterol concentrations in violent and nonviolent women suicide attempters. European Psychiatry 18, 23-27.
48. Virkkunen M (1983). Serum cholesterol levels in homicidal offenders. A low cholesterol level is connected with a habitually violent tendency under the influence of alcohol. Neuropsychobiology 10, 65-69.
49. Waage-Baudet H, Lauder JM, Dehart DB, Kluckman K, Hiller S, Tint GS, Sulik KK (2003). Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autism. International Journal of Developmental Neuroscience 21, 451-459.
50. Zoltowska M, Ziv E, Delvin E, Sinnett D, Kalman R, Garofalo C, Seidman E, Levy E (2003). Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes 52, 2539-2545.
51. Zureik M, Courbon D, Ducimetiere P (1996). Serum cholesterol concentration and death from suicide in men: Paris prospective study I. British Medical Journal 313, 649-651.